Translational research programs have been created to provide a better understanding of disease susceptibilities and pathway mechanisms. These programs require integration and analysis of multiple disparate data sets that come from different sources. Learn more about how NCI investigators utilize a centralized database system.
Download Document
Download Document
Related Insights

ADME Services
Accelerating your drug discovery, preclinical and clinical programs

Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform

Automation within an ADME Laboratory
Taking an assay from bench to an automated platform

Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Strategies for Effective Neutralizing Cell Based Assays in Early Immunogenicity Risk Assessment
Quantitative Assays for Peptides using LC-MS
Quantitative high-throughput analysis of peptide therapeutics and biomarkers to regulated bioanalytical standards
Hybrid Assays for Protein Bioanalysis
Combining immuno-affinity with liquid chromatography-mass spectrometry (LC-MS)

Absolute Bioavailability Analysis Using Stable Isotopes
A Liquid Chromatography-Tandem Mass Spectrometry Approach

Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series